IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Svennilson Peter

Q4 2018 Holdings

Filed 2019-02-13 | 8 holdings | $38.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Arcus Biosciences Inc.(RCUS)COM03969F109$38.1M3,540,85099.8%
Gritstone Oncology Inc.(2JQ)COM39868T105$47.9K3,102,9340.1%
Constellation Pharmceticls I(CNST)COM210373106$18.8K4,677,9380.0%
Immune Design Corp.COM45252L103$8.6K6,642,9420.0%